Mp47-04 Refining Selection Criteria for Neoadjuvant Chemotherapy in Patients With Muscle Invasive Bladder Cancer: Combining Clinical Risk Features and Intrinsic Molecular Subtypes
Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.1483
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2018
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)